Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity

Journal of Neurosurgery

Volumn 85, Issue 3, 1996, Pages 452-457

  Ordia, Joe I ^a   Fischer, Edward ^a   Adamski, Ellen ^a   Spatz, Edward L ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

baclofen; multiple sclerosis; programmable pump; spasticity; spinal cord injury

Indexed keywords

BACLOFEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MUSCLE HYPOTONIA; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SPASTICITY; SPINAL CORD INJURY; TREATMENT OUTCOME; URINE RETENTION; VERTIGO;

EID: 0029825058     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.85.3.0452     Document Type: Article

References (34)

1. Abel NA, Smith RA: Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehabil 75:54-58, 1994
2. Ashworth B: Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 192:540-542, 1964
3. Bowery NG: Baclofen: 10 years on. Trends Pharmacol Sci 3:400-403, 1982
4. Bushman W, Steers WD, Meythuler JM: Voiding dysfunction in patients with spastic paraplegia: urodynamic evaluation and response to continuous intrathecal baclofen. Neurourol Urodyn 12:163-170, 1993
5. Chabal C, Jacobson L. Terman G: Intrathecal fentanyl alleviates spasticity in the presence of tolerance to intrathecal baclofen. Anesthesiology 76:312-314, 1992
6. Coffey RJ, Cahill D, Steers W, et al: Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78:226-232, 1993
7. Corston RN, Johnson F, Godwin-Austen RB: The assessment of drug treatment of spastic gait. J Neurol Neurosurg Psychiatry 44:1035-1039, 1981
8. Delhaas EM. Brouwers JR: Intrathecal baclofen overdose: report of 7 events in 5 patients and review of the literature. Int J Clin Pharmacol Ther Toxicol 29:274-280, 1991
9. Erickson DL, Blackloek JB, Michaelson M, et al: Control of spasticity by implantable continuous flow morphine pump. Neurosurgery 16:215-217, 1985
10. Erickson DL, Moreno P, Lo J, et al: Control of spasticity with intrathecal morphine sulfate, in Müller H, Zierski J, Penn RD (eds): Local-Spinal Therapy of Spasticity. Berlin: Springer-Verlag, 1988, pp 137-142
11. Herman RM, D'Luzansky SC, Ippolito R: Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 8:338-345, 1992
12. Jones RF, Burke D, Marosszeky JE, et al: A new agent for the control of spasticity. J Neurol Neurosurg Psychiatry 33: 464-468, 1970
13. Kotler M, Kronenherg MF, Rifici C, et al: Epileptic seizures associated with intrathecal baclofen application. Neurology 44: 25-27, 1994
14. Kraft CH, van Eeden C: A Nonparametric Introduction to Statistics. New York: Macmillan, 1968
15. Kroin JS, Penn RD, Beissinger RL, et al: Reduced spinal reflexes following intrathecal baclofen in the rabbit. Exp Brain Res 54:191-194, 1984
16. Lance JW: Symposium synopsis, in Feldman RG, Young RR, Koella WP (eds): Spasticity: Disordered Motor Control. Chicago: Year Book, 1980, pp 485-494
17. Latash ML, Penn RD, Corcos DM, et al: Effects of intrathecal baclofen on voluntary motor control in spastic paresis. J Neurosurg 72:388-392, 1990
18. McDowell FH: Treatment of spasticity. Drugs 22:401-408, 1981
19. Müller H, Zierski J, Dralle D, et al: Intrathecal baclofen in spasticity, in Müller H, Zierski J, Penn RD (eds): Local-Spinal Therapy of Spasticity, Berlin: Springer-Verlag, 1988, pp 155-214
20. Müller-Schwefe G, Penn RD: Physostigmine in the treatment of intrathecal baclofen overdose. Report of three cases. J Neurosurg 71:273-275, 1989
21. Nance P, Schryvers O, Schmidt B, et al: Intrathecal baclofen therapy for adults with spinal spasticity: therapeutic efficacy and effect on hospital admissions. Can J Neurol Sci 22:22-29, 1995
22. Nanninga JB, Frost F, Penn R: Effect of intrathecal baclofen on bladder and sphincter function. J Urol 142:101-105, 1989
23. Ordia JI, Schultz BK: Intrathecal baclofen in the management of severe spasticity. Pharmacol Ther 19:461-472, 1994
24. Parke B, Penn RD, Savoy SM, et al: Functional outcome following delivery of intrathecal baclofen. Arch Phys Med Rehabil 70:30-32, 1989
25. Penn RD: Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77:236-240, 1992
26. Penn RD, Kroin JS: Continuous intrathecal baclofen for severe spasticity. Lancet 2:125-127, 1985
27. Penn RD, Kroin JS: Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1:1078, 1984 (Letter)
28. Penn RD, Savoy SM, Corcos D, et al: Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320:1517-1521, 1989
29. Rosenson AS, Ali A, Fordham EW, et al: Indium-111 DTPA flow study to evaluate surgically implanted drug pump delivery system. Clin Nucl Med 15:154-156, 1990
30. Steers WD, Meythaler JM, Haworth C, et al: Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. J Urol 148: 1849-1855, 1992
31. Taira T, Tanikawa T, Kawamura H, et al: Spinal intrathecal baclofen suppresses central pain after a stroke. J Neurol Neurosurg Psychiatry 57:381-382, 1994 (Letter)
32. Wilson PR, Yaksh TL: Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 51:323-330, 1978
33. Young RR, Delwaide PJ: Drug therapy: spasticity. N Engl J Med 304:96-99, 1981
34. Zierski J, Mueller H: Surgical treatment of spasticity - a review, in Müller H, Zierski J, Penn RD (eds): Local-Spinal Therapy of Spasticity, Berlin: Springer-Verlag, 1988, pp 255-263